Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through Global Industrial, Global Institutional & Specialty, and Global Healthcare & Life Sciences segments. The Global Industrial segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, metals and mining, power generation, pulp and paper, commercial laundry, petroleum, refining, and petrochemical industries. The Global Institutional & Specialty segment provides specialized cleaning and sanitizing products to the foodservice, hospitality, lodging, government and education, and retail industries. Its Global Healthcare & Life Sciences segment offers specialized cleaning and sanitizing products to the healthcare, personal care, and pharmaceutical industries, such as infection prevention and surgical solutions, and end-to-end cleaning and contamination control solutions under the Ecolab, Microtek, and Anios brand names. The company's Other segment offers pest elimination services to detect, eliminate, and prevent pests, such as rodents and insects in restaurants, food and beverage processors, educational and healthcare facilities, hotels, quick service restaurant and grocery operations, and other institutional and commercial customers. This segment also provides colloidal silica for binding and polishing applications in semiconductor, catalyst, and aerospace component manufacturing, as well as chemical industries; and products and services that manage wash process through custom designed programs, premium products, dispensing equipment, water and energy management, and reduction, as well as real time data management. It sells its products through field sales and corporate account personnel, distributors, and dealers. The company was founded in 1923 and is headquartered in Saint Paul, Minnesota.
Employees - 48000,
CEO - Mr. Christophe Beck,
Sector - Basic Materials,
Country - US,
Market Cap - 68.27B
Altman ZScore(max is 10): 4.93, Piotroski Score(max is 10): 9, Working Capital: $1409200000, Total Assets: $22101600000, Retained Earnings: $11228400000, EBIT: 2955400000, Total Liabilities: $13526100000, Revenue: $15674600000
AryaFin Target Price - $99.57 - Current Price $238.29 - Analyst Target Price $282.16
Ticker | ECL |
Index | S&P 500 |
Curent Price | 238.29 |
Change | 1.17% |
Market Cap | 68.27B |
Average Volume | 1.04M |
Income | 2.04B |
Sales | 15.67B |
Book Value/Share | 30.18 |
Cash/Share | 4.40 |
Dividend Est | 2.29 (0.96%) |
Dividend TTM | 2.36 (0.99%) |
Dividend Ex-Date | Dec 17, 2024 |
Employees | 48000 |
Moving Avg 20days | -3.27% |
Moving Avg 50days | -4.40% |
Moving Avg 200days | -0.93% |
Shares Outstanding | 283.20M |
Earnings Date | Oct 29 BMO |
Inst. Ownership | 78.21% |
Price/Earnings | 33.43 |
Forwad P/E | 31.79 |
PE Growth | 2.01 |
Price/Sales | 4.36 |
Price/Book | 7.89 |
Price/Cash | 54.13 |
Price/FCF | 34.09 |
Quick Ratio | 0.97 |
Current Ratio | 1.30 |
Debt/Equity | 0.97 |
Return on Assets | 9.30% |
Return on Equity | 25.02% |
Return on Investment | 12.72% |
Gross Margin | 43.15% |
Ops Margin | 16.20% |
Profit Margin | 13.04% |
RSI | 36.53 |
BETA(β) | 1.14 |
From 52week Low | 23.17% |
From 52week High | -9.26% |
EPS | 7.13 |
EPS next Year | 7.50 |
EPS next Qtr | 1.81 |
EPS this Year | 27.74% |
EPS next 5 Year | 16.59% |
EPS past 5 Year | -0.37% |
Sales past 5 Year | 1.38% |
EPS Y/Y | 66.18% |
Sales Y/Y | 4.13% |
EPS Q/Q | 82.87% |
Sales Q/Q | 1.02% |
Sales Surprise | -0.84% |
EPS Surprise | 0.48% |
ATR(14) | 4.20 |
Perf Week | -4.76% |
Perf Month | -1.44% |
Perf Quarter | -6.50% |
Perf Year | 22.29% |
Perf YTD | 20.14% |
Target Price | 282.16 |
AryaFin Engine© - An AI FinTech Venture - 2024 Disclaimer